Receiving contraception while admitted postpartum did not affect follow-up for women with gestational diabetes (GDM), a recent study found. Researchers performed a multivariate logistic regression to identify the association between immediate provision of postpartum contraception and attendance at the 6-week postpartum visits and performance of a 6 to 12 week oral glucose tolerance test, controlling for age, type of insurance, and race. They found:
- Women who received contraception prior to hospital discharge were less likely to attend their postpartum visit (aOR, 0.59), but just as likely to participate in postpartum diabetes screening (aOR, 1.27).
- Attendance at the postpartum visits was associated with private insurance (OR, 1.93).
Rosenthal EW, Easter SR, Morton-Eggleston EM, Dutton C, Zera C. Contraception and postpartum follow-up in patients with gestational diabetes. [Published online ahead of print November 14, 2016]. Contraception. doi:10.1016/j.contraception.2016.11.001.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al